ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 146 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2019. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $3,000 | -40.0% | 5,000 | 0.0% | 0.00% | -100.0% |
| Q4 2021 | $5,000 | -44.4% | 5,000 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $9,000 | -30.8% | 5,000 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $13,000 | -27.8% | 5,000 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $18,000 | +38.5% | 5,000 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $13,000 | 0.0% | 5,000 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $13,000 | -18.8% | 5,000 | 0.0% | 0.00% | -33.3% |
| Q2 2020 | $16,000 | +33.3% | 5,000 | 0.0% | 0.00% | +50.0% |
| Q1 2020 | $12,000 | -50.0% | 5,000 | 0.0% | 0.00% | -50.0% |
| Q4 2019 | $24,000 | +14.3% | 5,000 | 0.0% | 0.00% | +33.3% |
| Q3 2019 | $21,000 | -27.6% | 5,000 | 0.0% | 0.00% | -40.0% |
| Q2 2019 | $29,000 | +52.6% | 5,000 | 0.0% | 0.01% | +25.0% |
| Q1 2019 | $19,000 | +111.1% | 5,000 | 0.0% | 0.00% | +100.0% |
| Q4 2018 | $9,000 | – | 5,000 | +6072.8% | 0.00% | – |
| Q1 2018 | $0 | – | 81 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 17,815,708 | $47,033,000 | 2.93% |
| Essex Woodlands Management, Inc. | 2,764,908 | $7,130,000 | 2.60% |
| Belmont Global Advisors, Inc. | 973,000 | $2,569,000 | 2.01% |
| Belmont Global Advisors, Inc. | 135,700 | $358,000 | 0.28% |
| MSD Partners, L.P. | 2,750,000 | $7,260,000 | 0.22% |
| SFMG, LLC | 99,850 | $264,000 | 0.08% |
| Rotella Capital Management, Inc. | 11,090 | $29,000 | 0.03% |
| WESTPORT RESOURCES MANAGEMENT INC | 33,500 | $88,000 | 0.02% |
| SMITH ASSET MANAGEMENT GROUP LP | 236,590 | $625,000 | 0.02% |
| FRANKLIN STREET ADVISORS INC /NC | 41,150 | $109,000 | 0.02% |